InsiderClue
← All stocks

EXELIXIS, INC.

EXEL Net selling
CIK 0000939767 #814 in the set updated 18 Sep 2026
Bought (120 mo)
$16.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$349.82M
$12.08M on a plan · $240.94M straight out of an exercise
Sold at will
$96.81M
131 of 440 sales
Net
−$333.37M
−$80.35M against sales at will

By person

27 insiders · 499 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORRISSEY MICHAEL
President and CEO
—
$58.19M (59) scheduled
−$58.19M
3,810,385
1.54%
$204.47M
+520.8%
Haley Patrick J.
EVP, Commercial
—
$35.85M (70)
−$35.85M
357,638
0.1443%
$19.19M
+68.7%
Schwab Gisela
Pres, Prod Dev & Med Aff & CMO
—
$34.69M (36) scheduled
−$34.69M
689,078
0.2781%
$36.98M
+375.7%
Hessekiel Jeffrey
EVP & General Counsel
—
$28.18M (41) scheduled
−$28.18M
693,396
0.2798%
$37.21M
+191.6%
Lamb Peter
EVP, Scientific Strategy & CSO
—
$27.46M (26) scheduled
−$27.46M
410,958
0.1659%
$22.05M
+616.6%
Senner Christopher J.
EVP and CFO
—
$24.02M (17) scheduled
−$24.02M
952,317
0.3843%
$51.10M
+887.5%
SCANGOS GEORGE A
Director
—
$23.44M (42)
−$23.44M
714,717
0.2884%
$38.35M
−45.3%
PAPADOPOULOS STELIOS
Director
—
$16.81M (16)
−$16.81M
1,197,595
0.4833%
$64.26M
−3.3%
Aftab Dana
EVP, Research and Development
—
$16.67M (13)
−$16.67M
594,741
0.2400%
$31.91M
+131.3%
JOHNSON DAVID EDWARD
Director
$16.46M (5)
$2.60M (1)
+$13.85M
1,571,438
0.6342%
$84.32M
+72.5%
POSTE GEORGE
Director
—
$12.00M (15) scheduled
−$12.00M
127,199
0.0513%
$6.83M
+64.0%
WILLSEY LANCE
Director
—
$10.20M (13)
−$10.20M
424,415
0.1713%
$22.77M
−25.3%
MARCHESI VINCENT T
Director
—
$8.70M (12) scheduled
−$8.70M
93,989
0.0379%
$5.04M
−21.7%
Smith Julie
Director
—
$8.07M (6) scheduled
−$8.07M
28,957
0.0117%
$1.55M
—
WYSZOMIERSKI JACK L
Director
—
$7.73M (14) scheduled
−$7.73M
284,384
0.1148%
$15.26M
+317.5%
COHEN CHARLES
Director
—
$7.42M (8)
−$7.42M
261,375
0.1055%
$14.03M
+5.3%
Garber Alan M
Director
—
$7.13M (14) scheduled
−$7.13M
35,703
0.0144%
$1.92M
−39.7%
FELDBAUM CARL B
Director
—
$6.83M (14) scheduled
−$6.83M
18,701
0.0075%
$1.00M
−61.6%
Peterson Amy C.
EVP Prod Dev & Med Aff & CMO
—
$3.31M (1) scheduled
−$3.31M
465,393
0.1878%
$24.97M
—
Freire Maria C
Director
—
$2.92M (4) scheduled
−$2.92M
109,186
0.0441%
$5.86M
—
Beckerle Mary C
Director
—
$2.36M (6) scheduled
−$2.36M
16,079
0.0065%
$862.80K
—
Oliver Bob
Director
—
$2.02M (3) scheduled
−$2.02M
29,487
0.0119%
$1.58M
—
Eckhardt Sue Gail
Director
—
$1.87M (6) scheduled
−$1.87M
16,079
0.0065%
$862.80K
—
Hefti Brenda
SVP and General Counsel
—
$1.15M (2) scheduled
−$1.15M
106,762
0.0431%
$5.73M
+17.8%
Heyman Tomas J.
Director
—
$201.25K (1)
−$201.25K
50,649
0.0204%
$2.72M
—
Goodman Vicki L
EVP, Prod Dev & Med Aff &CMO
—
—
—
307,654
0.1242%
$16.51M
—
Wright Jacqueline
Director
—
—
—
51,756
0.0209%
$2.78M
—

Individual transactions

64
Insider
Date
Role
Action
Shares
Price
Amount
Aftab Dana
26 May 2026
EVP, Research and Development
Sell
43,451
$50.35
$2.19M
Haley Patrick J.
20 May 2026
EVP, Commercial
Sell
32,110
$49.81
$1.60M
Senner Christopher J.
18 May 2026
EVP and CFO
Sell
34,901
$50.00
$1.75M
POSTE GEORGE
7 May 2026
Director
Sell
60,000
$45.71
$2.74M
Aftab Dana
24 Feb 2026
EVP, Research and Development
Sell
47,918
$44.50
$2.13M
Aftab Dana
19 Feb 2026
EVP, Research and Development
Sell
29,873
$44.35
$1.32M
Haley Patrick J.
17 Feb 2026
EVP, Commercial
Sell
64,778
$43.50
$2.82M
Haley Patrick J.
17 Feb 2026
EVP, Commercial
Sell
3,036
$43.84
$133.10K
Senner Christopher J.
17 Feb 2026
EVP and CFO
Sell
30,617
$43.67
$1.34M
Senner Christopher J.
13 Feb 2026
EVP and CFO
Sell
34,278
$43.00
$1.47M
Haley Patrick J.
21 Nov 2025
EVP, Commercial
Sell
28,043
$42.58
$1.19M
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell indirect
10,648
$41.77
$444.77K
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell indirect
23,539
$41.93
$986.99K
Haley Patrick J.
20 Nov 2025
EVP, Commercial
Sell
10,000
$42.11
$421.10K
PAPADOPOULOS STELIOS
12 Nov 2025
Director
Sell
100,000
$43.55
$4.36M
Aftab Dana
11 Nov 2025
EVP, Research and Development
Sell
48,383
$42.50
$2.06M
Heyman Tomas J.
21 May 2025
Director
Sell
4,544
$44.29
$201.25K
Haley Patrick J.
20 May 2025
EVP, Commercial
Sell
34,387
$44.06
$1.52M
Hessekiel Jeffrey
15 May 2025
EVP & General Counsel
Sell
25,000
$46.18
$1.15M
Aftab Dana
24 Feb 2025
CSO/EVP Disc & Trans Research
Sell
26,987
$36.75
$991.77K
Haley Patrick J.
24 Feb 2025
EVP, Commercial
Sell
52,636
$36.98
$1.95M
Hessekiel Jeffrey
29 Nov 2024
EVP & General Counsel
Sell
60,000
$36.67
$2.20M
POSTE GEORGE
1 Nov 2024
Director
Sell
30,000
$34.00
$1.02M
Freire Maria C
14 Aug 2024
Director
Sell
8,250
$26.56
$219.12K
Aftab Dana
12 Aug 2024
CSO/EVP Disc & Trans Research
Sell
20,883
$27.06
$565.09K
POSTE GEORGE
8 Aug 2024
Director
Sell
33,725
$26.89
$906.87K
Smith Julie
21 May 2024
Director
Sell
27,280
$21.12
$576.15K
Haley Patrick J.
23 Feb 2024
EVP, Commercial
Sell
47,020
$21.45
$1.01M
JOHNSON DAVID EDWARD
27 Nov 2023
Director
Sell indirect
120,409
$21.61
$2.60M
Haley Patrick J.
3 Aug 2023
EVP, Commercial
Sell
30,553
$20.67
$631.53K
Haley Patrick J.
27 May 2022
EVP, Commercial
Sell
18,812
$18.21
$342.57K
Hessekiel Jeffrey
16 May 2022
EVP, General Counsel & Sec
Sell
18,000
$20.07
$361.26K
Hessekiel Jeffrey
29 Mar 2022
EVP, General Counsel & Sec
Sell
13,283
$22.00
$292.23K
Hessekiel Jeffrey
28 Mar 2022
EVP, General Counsel & Sec
Sell
4,717
$22.00
$103.77K
Haley Patrick J.
25 Feb 2022
EVP, Commercial
Sell
31,238
$19.53
$610.08K
Hessekiel Jeffrey
24 Feb 2022
EVP and General Counsel
Sell
18,000
$20.00
$360.00K
PAPADOPOULOS STELIOS
22 Feb 2022
Director
Sell
84,515
$19.56
$1.65M
Haley Patrick J.
24 Nov 2021
EVP, Commercial
Sell
17,236
$17.25
$297.32K
Hessekiel Jeffrey
1 Nov 2021
EVP and General Counsel
Sell
5,117
$22.03
$112.73K
Hessekiel Jeffrey
15 Oct 2021
EVP and General Counsel
Sell
12,883
$22.02
$283.68K
Haley Patrick J.
18 May 2021
EVP, Commercial
Sell
14,593
$24.73
$360.88K
Hessekiel Jeffrey
17 May 2021
EVP, General Counsel & Sec
Sell
18,000
$25.39
$457.02K
POSTE GEORGE
14 May 2021
Director
Sell
40,802
$24.97
$1.02M
Freire Maria C
11 May 2021
Director
Sell
8,275
$25.01
$206.96K
Hessekiel Jeffrey
26 Apr 2021
EVP and General Counsel
Sell
18,000
$25.03
$450.54K
Haley Patrick J.
26 Apr 2021
EVP, Commercial
Sell
7,665
$25.03
$191.85K
MARCHESI VINCENT T
22 Feb 2021
Director
Sell
24,097
$22.29
$537.12K
WILLSEY LANCE
16 Feb 2021
Director
Sell
50,000
$21.90
$1.10M
Haley Patrick J.
12 Feb 2021
EVP, Commercial
Sell
45,000
$21.57
$970.65K
Haley Patrick J.
20 Jul 2020
EVP, Commercial
Sell
3,151
$25.36
$79.91K
Garber Alan M
22 May 2020
Director
Sell
36,111
$24.42
$881.83K
Haley Patrick J.
20 May 2020
EVP, Commercial
Sell
3,151
$24.99
$78.74K
SCANGOS GEORGE A
18 May 2020
Director
Sell
75,000
$25.96
$1.95M
SCANGOS GEORGE A
24 Apr 2020
Director
Sell
15,000
$26.24
$393.60K
SCANGOS GEORGE A
23 Apr 2020
Director
Sell
55,700
$26.23
$1.46M
SCANGOS GEORGE A
23 Apr 2020
Director
Sell
44,300
$25.68
$1.14M
SCANGOS GEORGE A
22 Apr 2020
Director
Sell
4,200
$25.05
$105.21K
SCANGOS GEORGE A
21 Apr 2020
Director
Sell
5,800
$25.04
$145.23K
SCANGOS GEORGE A
20 Apr 2020
Director
Sell
5,900
$24.70
$145.73K
SCANGOS GEORGE A
20 Apr 2020
Director
Sell
25,600
$24.07
$616.19K
SCANGOS GEORGE A
20 Apr 2020
Director
Sell
18,500
$23.39
$432.72K
SCANGOS GEORGE A
15 Apr 2020
Director
Sell
25,000
$18.31
$457.75K
SCANGOS GEORGE A
8 Apr 2020
Director
Sell
7,065
$18.35
$129.64K
SCANGOS GEORGE A
7 Apr 2020
Director
Sell
16,435
$18.25
$299.94K
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 712
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,691,176
Sales filed before the plan box existed 101
History held since 2 Sep 2016